Shanghai Xuerong BiotechnologyLtd Balance Sheet Health
Financial Health criteria checks 0/6
Shanghai Xuerong BiotechnologyLtd has a total shareholder equity of CN¥1.3B and total debt of CN¥2.3B, which brings its debt-to-equity ratio to 180.9%. Its total assets and total liabilities are CN¥4.4B and CN¥3.1B respectively.
Key information
180.9%
Debt to equity ratio
CN¥2.32b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥193.09m |
| Equity | CN¥1.28b |
| Total liabilities | CN¥3.10b |
| Total assets | CN¥4.38b |
Recent financial health updates
No updates
Recent updates
Shanghai Xuerong Biotechnology Co.,Ltd. (SZSE:300511) Shares Fly 48% But Investors Aren't Buying For Growth
Oct 08
Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Price Is Right But Growth Is Lacking After Shares Rocket 45%
Aug 19Little Excitement Around Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Revenues As Shares Take 31% Pounding
Jun 27There's No Escaping Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Muted Revenues Despite A 25% Share Price Rise
May 13Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Shares Bounce 25% But Its Business Still Trails The Industry
Mar 15Financial Position Analysis
Short Term Liabilities: 300511's short term assets (CN¥640.1M) do not cover its short term liabilities (CN¥1.4B).
Long Term Liabilities: 300511's short term assets (CN¥640.1M) do not cover its long term liabilities (CN¥1.7B).
Debt to Equity History and Analysis
Debt Level: 300511's net debt to equity ratio (165.9%) is considered high.
Reducing Debt: 300511's debt to equity ratio has increased from 93.3% to 180.9% over the past 5 years.
Debt Coverage: 300511's debt is not well covered by operating cash flow (16.2%).
Interest Coverage: Insufficient data to determine if 300511's interest payments on its debt are well covered by EBIT.